Your session is about to expire
← Back to Search
Nurse-Led Telemonitoring for Chronic Conditions
N/A
Recruiting
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must have been discharged from hospital within 2 weeks during their recruitment into the study (or will be recruited prior to their discharge)
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months and at 1-year
Awards & highlights
Study Summary
This trial will help bridge the gap in treatment of seniors with multiple chronic conditions by introducing nurse-led integrated care model & telemonitoring to improve coordination & self-care.
Who is the study for?
The SMaRT Study is for adults over 18 who have recently been discharged from certain hospitals in Canada and have at least one chronic condition like heart failure, COPD, high blood pressure, diabetes, or depression. Participants need to be able to use the telemonitoring app and devices (like a weight scale) and speak English or have someone who can communicate for them.Check my eligibility
What is being tested?
This study tests the SMaRT Clinic model which uses nurse-led care coordinated through telemonitoring to manage patients with multiple chronic conditions after they leave the hospital. It aims to improve self-care education and clinical coordination across patient care teams.See study design
What are the potential side effects?
Since this trial involves a healthcare service intervention rather than medication, traditional side effects are not applicable. However, participants may experience issues related to using technology such as privacy concerns or technical difficulties.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was discharged from the hospital less than 2 weeks ago or will be before joining the study.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months and at 1-year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months and at 1-year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
All-cause mortality
Days alive and out-of-hospital
Death and/or all-cause unplanned readmission
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemonitoring (Medly MCC)Experimental Treatment1 Intervention
Medly is a smartphone application allows patients with heart failure, diabetes, depression, hypertension, and/or COPD to measure and record their daily self-reported symptoms. This monitoring information is then transmitted wirelessly to a data server where an algorithm is used to generate an alert to a healthcare provider as necessary. The patient also receives an automated self-care message based on their measurements and reported symptoms.
Group II: ControlActive Control1 Intervention
Control groups will be compared to 350 patients who received standard of care via propensity-matched controls from the ICES provincial database.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medly
2016
N/A
~100
Find a Location
Who is running the clinical trial?
Markham Stouffville HospitalOTHER
3 Previous Clinical Trials
2,117 Total Patients Enrolled
Health Sciences NorthOTHER
4 Previous Clinical Trials
702 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,475 Previous Clinical Trials
484,740 Total Patients Enrolled
10 Trials studying Diabetes
2,688 Patients Enrolled for Diabetes
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a chronic condition like heart failure or diabetes that could improve with telemonitoring.I was discharged from the hospital less than 2 weeks ago or will be before joining the study.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Telemonitoring (Medly MCC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there numerous US-based medical centers running this research venture?
"Execution of this trial is dependent on the recruitment of 4 participating patients. William Osler Health System in Brampton, Health Sciences North in Sudbury, and Women's College Hospital in Toronto are 3 of these sites; a further 4 locations need to be engaged as well."
Answered by AI
Are there currently opportunities for individuals to join this investigation?
"Indeed, clinicaltrials.gov reveals that this clinical trial is actively recruiting participants since its initial posting on October 17th 2022. Most recently updated on November 24th 2022, the study seeks 350 patients to be enrolled in 4 different sites."
Answered by AI
What is the cap on the number of participants for this trial?
"Affirmative. According to clinicaltrials.gov, this experiment is recruiting participants as of today's date; the trial was first published on October 17th 2022 and updated most recently on November 24th 2022. 350 individuals are needed between 4 separate medical sites."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger